Related Experiment Video
Updated: Dec 10, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Percutaneous coronary intervention provided better long term results than optimal medical therapy alone in patients
Dibbendhu Khanra1, Vikas Mishra2, Bhavna Jain3
1New Cross Hospital, Royal Wolverhampton NHS Trust, UK.
Insights
Percutaneous coronary intervention (PCI) plus optimal medical therapy (OMT) significantly reduces major adverse cardiovascular events and mortality in chronic total occlusion (CTO) patients compared to OMT alone. Long-term outcomes favor PCI, with similar revascularization rates.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Chronic total occlusion (CTO) management often involves percutaneous coronary intervention (PCI) alongside optimal medical therapy (OMT), but comparative long-term outcome data are limited.
- Existing studies on PCI+OMT versus OMT alone for CTO have design limitations, including observational data, variable follow-up, and high patient drop-out or cross-over rates.
Purpose of the Study:
- To conduct a comprehensive meta-analysis of both observational and randomized studies.
- To compare the long-term clinical outcomes of PCI plus OMT versus OMT alone in patients with CTO.
Main Methods:
- Systematic review of PubMed, Embase, and Cochrane databases.
- Inclusion of 15 studies, with quality appraisal using the Newcastle Ottawa scale.
- Random-effects model with inverse variance method to analyze data on major adverse cardiovascular events (MACE), mortality, and revascularization.
Main Results:
- PCI+OMT significantly reduced MACE (cardiac death, myocardial infarction, stroke, unplanned revascularization) compared to OMT alone (RR: 0.76; 95% CI: 0.61-0.95).
- All-cause mortality and cardiac death were significantly lower in the PCI+OMT group (P<0.00001 for both).
- While myocardial infarction and stroke rates were lower with PCI+OMT, they did not reach statistical significance. Unplanned revascularization rates were similar between groups.
Conclusions:
- Percutaneous coronary intervention for CTO, when combined with optimal medical therapy, leads to improved long-term outcomes.
- Key benefits include a reduction in major adverse cardiovascular events, all-cause mortality, and cardiac death.
- The rates of unplanned revascularization remain comparable between the PCI+OMT and OMT alone strategies.
Aims:
Studies comparing the outcome of percutaneous coronary intervention (PCI) along with optimal medical therapy (OMT) versus OMT alone in treatment of chronic total occlusion (CTO) are limited by observational design, variable follow-up period, diverse clinical outcomes, high drop-out and cross-over rates. This study aims to conduct a meta-analysis of published data of observational as well as randomized studies comparing long term outcomes of PCI+OMT versus OMT alone.
Methods And Results:
PubMed, Embase and Cochrane databases were systematically reviewed. 15 studies meeting criteria were included in the meta-analysis. The New-castle Ottawa scale was used to appraise the overall quality of the studies. Random-effects model with inverse variance method was undertaken. Major adverse cardiovascular events (MACE) which comprises of cardiac death, myocardial infarction, stroke, and un-planned revascularization were significantly lower in the PCI+OMT group (RR:0.76; 95% CI:0.61 to 0.95; P=<0.00001; I2 = 85%). All-cause mortality and cardiac death were significantly lower in the PCI+OMT group (P=<0.00001 in both). Myocardial infarction and stroke rates were lower in the PCI+OMT group, however they did not reach statistical significance (P = 0.24, P = 0.15 respectively). Unplanned revascularizations (of any vessel) were also similar in both the groups (P = 0.78, I2 = 88%).
Conclusion:
PCI of CTO is rewarded with better long term outcome, in terms of MACE, all-cause mortality and cardiac death with similar rates of un-planned revascularization.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
04:30A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis III: Management